Breaking News Instant updates and real-time market news.

T

AT&T

$35.00

0.11 (0.32%)

, TWX

Time Warner

$96.02

-0.32 (-0.33%)

19:25
04/24/18
04/24
19:25
04/24/18
19:25

AT&T lawyer grills star U.S. witness over data in pay-TV study, Bloomberg says

The U.S. government's star witness in the trial over AT&T's (T) proposed acquisition of Time Warner (TWX) said he erred in previous testimony over data used to predict that the tie-up will raise pay-TV prices for consumers by hundreds of millions of dollars per year, Bloomberg reports. University of California-Berkeley professor Carl Shapiro, whose report forms the basis of the DOJ's lawsuit to block the proposed merger, has repeatedly clashed with defense lawyers over the accuracy of the data used to predict the effects of the merger on competitors and customers, the report notes. Shapiro was grilled by an AT&T lawyer about a data point he claimed was crucial to his findings and was dramatically contradicted for the second time, the report says. Reference Link

T

AT&T

$35.00

0.11 (0.32%)

TWX

Time Warner

$96.02

-0.32 (-0.33%)

  • 24

    Apr

  • 25

    Apr

T AT&T
$35.00

0.11 (0.32%)

04/12/18
OPCO
04/12/18
NO CHANGE
OPCO
T-Mobile, Sprint merger logic, still difficult to consummate, says Oppenheimer
Oppenheimer analyst Timothy Horan notes that The Wall Street Journal reported on revived preliminary merger talks after T-Mobile (TMUS)/Sprint (S) ended previous M&A discussions five months ago. The analyst believes a merger offers long-term value for both companies through better scale and synergies, but friction will center on control, relative valuation and regulatory approval concessions, which need to be agreed upon up-front. Ultimately, Horan thinks the industry will consolidate to four large companies that will all offer a quad-play service, one possibility being T-Mobile/Sprint, AT&T (T), Verizon (VZ)/Dish (DISH) and a combination of the cable companies/wireless assets.
04/12/18
NOMU
04/12/18
NO CHANGE
Target $48
NOMU
Buy
CommScope price target raised to $48 from $42 at Nomura Instinet
Nomura Instinet analyst Jeffrey Kvaal raised his price target for CommScope (COMM) to $48 saying "rapidly increasing" AT&T (T) FirstNet spending will lift the company's 2018 revenues "easily above consensus expectations." FirstNet represents a "rare inflection in a typically methodical story," Kvaal tells investors in a research note. He keeps a Buy rating on CommScope.
04/17/18
PIVT
04/17/18
DOWNGRADE
Target $105
PIVT
Hold
Time Warner downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Time Warner (TWX) to Hold and lowered his price target for the shares to $105 from $108. The stock's value is driven by current trading levels of AT&T (T) under a presumption that the sale of the company goes through, Wieser tells investors in a research note.
04/23/18
MSCO
04/23/18
NO CHANGE
MSCO
DOJ eSim probe could be positive for smaller carriers, says Morgan Stanley
After the New York Times reported that the Justice Department has opened an investigation into potential collusion by AT&T (T), Verizon (VZ) and the GSMA to hinder the deployment of eSIM technology, Morgan Stanley analyst Simon Flannery said the news could be seen as a potential positive for the smaller carriers if the DoJ takes steps to make it easier for consumers to switch wireless carriers. He believes both T-Mobile (TMUS) and Sprint (S) would see an opportunity to take market share if eSIMs were introduced more broadly, Flannery tells investors.
TWX Time Warner
$96.02

-0.32 (-0.33%)

03/19/18
JEFF
03/19/18
UPGRADE
Target $82
JEFF
Buy
Amdocs upgraded to Buy from Hold at Jefferies
Jefferies analyst Ramsey El-Assal upgraded Amdocs (DOX) to Buy and raised his price target for the shares to $82 from $70. Past mergers suggest that the AT&T (T) spend slowdown related to its acquisition of Time Warner (TWX) is only temporary, El-Assal tells investors in a research note. He believes a recovery is "on the horizon regardless of whether the merger is approved or not." The analyst sees upside to fiscal 2019 estimates for Amdocs.
03/23/18
WELS
03/23/18
NO CHANGE
Target $40
WELS
Outperform
AT&T price target lowered to $40 from $48 Wells Fargo
Wells Fargo analyst Jennifer Fritzsche lowered her price target for AT&T (T) to $40 from $48 given recent volatility and uncertainty around Time Warner (TWX) path. Nonetheless, the analyst reiterates an Outperform rating on AT&T shares and believes Q1 2018 will represent the second consecutive quarter of positive handset ads for the company.
04/11/18
JEFF
04/11/18
NO CHANGE
JEFF
T-Mobile, Sprint deal has more hurdles than AT&T, Time Warner, says Jefferies
A horizontal merger between T-Mobile (TMUS) and Sprint (S) poses more significant regulatory hurdles than the contested AT&T (T), Time Warner (TWX) deal does, Jefferies analyst Scott Goldman tells investors in a research note after the Wall Street Journal reported the two companies are again in merger talks. The analyst believes potential regulatory remedies could include meaningful spectrum divestitures. With that said, he thinks the combined company would create "meaningful accretion," with free cash flow per share nearly 30% higher in year three. Using multiple analysis, Goldman thinks T-Mobile shares could be worth more than $88 in a deal scenario. The stock closed yesterday up 3.4% to $63.13. Further, the analyst recommends buying the tower stocks on yesterday's selloff given his view of significant regulatory hurdles for a Sprint, T-Mobile deal. He has Buy ratings on American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC).

TODAY'S FREE FLY STORIES

NKTR

Nektar

$82.81

0.87 (1.06%)

, BMY

Bristol-Myers

$52.49

0.14 (0.27%)

05:36
05/24/18
05/24
05:36
05/24/18
05:36
Recommendations
Nektar, Bristol-Myers, Merck analyst commentary  »

Nektar is…

NKTR

Nektar

$82.81

0.87 (1.06%)

BMY

Bristol-Myers

$52.49

0.14 (0.27%)

MRK

Merck

$59.16

0.7 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 02

    Jun

  • 05

    Jun

  • 12

    Jun

  • 10

    Jul

  • 10

    Sep

  • 23

    Oct

ABBV

AbbVie

$105.60

-0.72 (-0.68%)

05:34
05/24/18
05/24
05:34
05/24/18
05:34
Downgrade
AbbVie rating change  »

AbbVie downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 05

    Jun

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

, IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

05:29
05/24/18
05/24
05:29
05/24/18
05:29
Downgrade
Guaranty Bancorp, Independent Bank rating change  »

Guaranty Bancorp…

GBNK

Guaranty Bancorp

$33.05

0.6 (1.85%)

IBTX

Independent Bank

$74.20

-3.65 (-4.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EC

Ecopetrol

$21.15

-0.62 (-2.85%)

05:28
05/24/18
05/24
05:28
05/24/18
05:28
Upgrade
Ecopetrol rating change  »

Ecopetrol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRML

Vermillion

$1.05

0.045 (4.48%)

05:27
05/24/18
05/24
05:27
05/24/18
05:27
Downgrade
Vermillion rating change  »

Vermillion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.50

-0.15 (-1.19%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Initiation
Caesars initiated  »

Caesars initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$6.25

-0.2 (-3.10%)

05:26
05/24/18
05/24
05:26
05/24/18
05:26
Syndicate
Melinta Therapeutics 22M share Secondary priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

TDY

Teledyne

$198.96

2.19 (1.11%)

05:24
05/24/18
05/24
05:24
05/24/18
05:24
Hot Stocks
Teledyne awarded second phase of $47M contract from ESA »

The European Space…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$2.69

0.06 (2.28%)

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Northern Oil and Gas rating change  »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDC

Rowan Companies

05:22
05/24/18
05/24
05:22
05/24/18
05:22
Upgrade
Rowan Companies rating change  »

Rowan Companies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OI

Owens-Illinois

$18.85

-0.1 (-0.53%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Owens-Illinois rating change  »

Owens-Illinois upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$156.59

1.52 (0.98%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Upgrade
Deere rating change  »

Deere upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNRC

Generac

$50.56

0.42 (0.84%)

05:21
05/24/18
05/24
05:21
05/24/18
05:21
Downgrade
Generac rating change  »

Generac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBR

Petrobras

$15.10

-0.6 (-3.82%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Downgrade
Petrobras rating change  »

Petrobras downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$76.38

-0.465 (-0.61%)

05:19
05/24/18
05/24
05:19
05/24/18
05:19
Hot Stocks
Sandoz receives European Commission approval for Zessly »

Sandoz, a Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ARCT

Arcturus Therapeutics

$6.66

-0.29 (-4.17%)

05:17
05/24/18
05/24
05:17
05/24/18
05:17
Hot Stocks
Arcturus Therapeutics comments on court ruling on former CEO 13D situation »

Arcturus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

MTDR

Matador

$31.07

-0.735 (-2.31%)

05:14
05/24/18
05/24
05:14
05/24/18
05:14
Recommendations
Matador analyst commentary  »

Matador 'geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESYJY

easyJet

$0.00

(0.00%)

05:08
05/24/18
05/24
05:08
05/24/18
05:08
Downgrade
easyJet rating change  »

easyJet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRMW

Primo Water

$15.48

0.56 (3.75%)

05:05
05/24/18
05/24
05:05
05/24/18
05:05
Initiation
Primo Water initiated  »

Primo Water initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALGN

Align Technology

$308.24

10.26 (3.44%)

05:04
05/24/18
05/24
05:04
05/24/18
05:04
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

CDNA

CareDx

$11.66

-0.12 (-1.02%)

04:55
05/24/18
05/24
04:55
05/24/18
04:55
Conference/Events
CareDx management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

Philadelphia Federal…

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

3-Month Bill Announcement…

04:55
05/24/18
05/24
04:55
05/24/18
04:55
General news
Breaking General news story  »

4-Week Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.